"In my view, Philip Morris USA defense on appeal might well be successful," Martin Feldman, a tobacco analyst at Merrill Lynch, said, "but until that point these lights claims are now particularly challenging for PMUSA and the other tobacco defendants."
"In essence, for both the industry and investors in the industry this is a new category of claim to have to worry about," Feldman said.



